Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy

N/ATerminatedNCT01907191

Trinity Health Of New England23 enrolled

Overview

This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours

Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Hip Injuries

Interventions

liposomal bupivacaineDRUG

(Ultrasound guided injection of liposomal bupivacaine) for patients undergoing hip arthroscopy

BupivacaineDRUG

(around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients having hip arthroscopy Exclusion Criteria: * History of neurologic disease, neuropathy, diabetes * Allergy to local anesthetic solution * Chronic use of narcotics * Inability to give consent/cooperate with study * History of previous hip arthroscopy on the ipsilateral side * Pregnancy

Locations (1)

Saint Francis Hospital and Medical Center

Hartford, Connecticut, United States

Outcomes

Primary Outcomes

Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)

Consumption of 5mg Oxycontin tablets will be assessed on Post Operative Days 1, 2 \& 3.

Time frame: Post Operative Day 1, 2 & 3

Secondary Outcomes

Pain Scores

Analysis of pain scores (at rest and ambulation) during hospital stay. Measured on a 10 point pain scale (1 being no pain and 10 being worst pain imaginable)

Time frame: Post Operative Day 1, 2 & 3

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.